MedTrace Logo

To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus Antiplatelets in the Acute Treatment of Patients With Cervical Artery Dissection

NCT00238667 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2015-05-20

No results posted yet for this study

Summary

This is a feasibility study to determine if a sufficient number of patients can be recruited throughout the United Kingdom and whether sufficient endpoints can be generated for a full scale therapeutic trial of anticoagulants versus antiplatelets in acute cervical artery dissection treatment.

Conditions

  • Cervical Artery Dissection
  • Carotid Artery Dissection
  • Vertebral Artery Dissection
  • Stroke

Interventions

DRUG

Antiplatelet (Aspirin, Dipyridamole, clopidogrel)

DRUG

Anticoagulant (Unfractionated Heparin, LMW Heparin, Warfarin)

Sponsors & Collaborators

  • The Stroke Association, United Kingdom

    collaborator OTHER

  • St George's, University of London

    lead OTHER

Principal Investigators

  • Professor John W Norris, MD, FRCP · St George's, University of London

  • Professor Hugh Markus, DM, FRCP · St George's, University of London

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30
Completion
2014-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00238667 on ClinicalTrials.gov